VENLAFAXINE HYDROCHLORIDE
- Product NDC
- 43602-392
- 11-digit product format
- 436020392
- Labeler code
- 43602
- Product ID
- 43602-392_01685dfa-31a2-4b5a-a4d7-bf4a27e19f56
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Ascent Pharmaceuticals, Inc.
- Application
- ANDA214419
- Marketing category
- ANDA
- Marketing start
- 2020-10-23
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 38 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43602-392 | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) TABLET, EXTENDED RELEASE [ASCENT PHARMACEUTICALS, INC.] | 2 | Legacy NDC | 20201029_fa72c746-a640-4d67-9acd-6fe5f3804a10.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43602-392-05 | 43602039205 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-392-05) | 2020-10-23 | 0000-00-00 | No | No | Current |
| 43602-392-30 | 43602039230 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-392-30) | 2020-10-23 | 0000-00-00 | No | No | Current |